Zhu L et al. |
[Effect of CYP3A4*18B, CYP3A5*3 gene polymorphism on dosage and concentration of tacrolimus in renal transplant patients]. |
2012 |
Yao Xue Xue Bao |
pmid:22993851
|
Wang M et al. |
Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection. |
2002 |
Yan Ke Xue Bao |
pmid:15510746
|
Li S et al. |
Experiment study of retinal ultrastructure after intravitreal FK506. |
2004 |
Yan Ke Xue Bao |
pmid:15124532
|
Xie H et al. |
Effect of topical FK506 used alone or combined with keratoplasty on patients with recurrent Mooren's corneal ulcer. |
2006 |
Yan Ke Xue Bao |
pmid:17378150
|
Ma H et al. |
[The effect of FK506 on the proliferation of HRCECs]. |
2006 |
Yan Ke Xue Bao |
pmid:17378157
|
Kagaya H et al. |
Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients. |
2006 |
Yakugaku Zasshi |
pmid:17139160
|
Tayama Y et al. |
[Influence of tacrolimus and ciprofloxacin on glucose metabolism]. |
2007 |
Yakugaku Zasshi |
pmid:17978565
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Yamaguchi K et al. |
[Case of encephalopathy seemingly caused by tacrolimus at blood concentration near the upper limit of therapeutic range]. |
2012 |
Yakugaku Zasshi |
pmid:22790031
|
Nagao K et al. |
[Drug development from natural fermentation products: establishing a manufacturing process which maximizes the potential of microorganisms]. |
2010 |
Yakugaku Zasshi |
pmid:21048405
|
Fukudo M |
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. |
2007 |
Yakugaku Zasshi |
pmid:17603267
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Tanaka H et al. |
[Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. |
1997 |
Yakugaku Zasshi |
pmid:9306728
|
Muraki Y |
[Factors affecting the pharmacokinetics after living donor liver transplant]. |
2012 |
Yakugaku Zasshi |
pmid:23023417
|
Iwamoto T et al. |
[Successful treatment by tacrolimus in two patients with Osserman's grade III intractable myasthenia gravis and elderly IIb]. |
2004 |
Yakugaku Zasshi |
pmid:15067188
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Niwa T et al. |
Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. |
2007 |
Yakugaku Zasshi |
pmid:17202802
|
Shimizu K |
Development of New Liposome Targeting Strategies for Application of Disease Therapies. |
2017 |
Yakugaku Zasshi |
pmid:28049894
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|
Li J et al. |
[Regulatory effect of FK506 on the expression of CD152 and PD-1 in the liver allo-recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18177621
|
He QH et al. |
[The role of superantigen SEB-induced immunotolerance in the immune privileged site]. |
2003 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15132898
|
Bai YJ et al. |
[Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. |
2008 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:18845086
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|
Imamura R et al. |
ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. |
2006 |
Xenotransplantation |
pmid:16623807
|
Song Z et al. |
Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig-to-rat model. |
2003 |
Xenotransplantation |
pmid:14617270
|
Balamurugan AN et al. |
Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats. |
2007 |
Xenotransplantation |
pmid:17669173
|
Miki T et al. |
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. |
2001 |
Xenotransplantation |
pmid:11472629
|
Tachibana A et al. |
Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. |
2013 Jul-Aug |
Xenotransplantation |
pmid:23683097
|
Zhou YN et al. |
Effect of amlodipine on the pharmacokinetics of tacrolimus in rats. |
2013 |
Xenobiotica |
pmid:23312000
|
Picard N |
The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus". |
2013 |
Xenobiotica |
pmid:23339626
|
Fujiyama N et al. |
Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. |
2009 |
Xenobiotica |
pmid:19274604
|
Tata PN et al. |
Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). |
2009 |
Xenobiotica |
pmid:19604035
|
Zhang S et al. |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. |
2012 |
Xenobiotica |
pmid:22106961
|
Ogawa K et al. |
A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. |
2013 |
Xenobiotica |
pmid:23153054
|
Lu XF et al. |
Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice. |
2017 |
Xenobiotica |
pmid:27533047
|
Zhu L et al. |
Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. |
2015 |
Xenobiotica |
pmid:25869250
|
Lampen A et al. |
Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. |
1998 |
Xenobiotica |
pmid:9622846
|
Jeong H and Chiou WL |
Role of P-glycoprotein in the hepatic metabolism of tacrolimus. |
2006 |
Xenobiotica |
pmid:16507509
|
Patel CG et al. |
Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. |
2013 |
Xenobiotica |
pmid:22934787
|
Chitnis SD et al. |
Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. |
2013 |
Xenobiotica |
pmid:23278282
|
Miura M et al. |
Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. |
2005 |
Xenobiotica |
pmid:16012079
|
Niioka T et al. |
Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. |
2015 |
Xenobiotica |
pmid:26189776
|
Gupta AS et al. |
Pyoderma Gangrenosum of the Scalp: A Rare Clinical Variant. |
2018 |
Wounds |
pmid:29481333
|
Kiyama T et al. |
Tacrolimus enhances colon anastomotic healing in rats. |
2002 Sep-Oct |
Wound Repair Regen |
pmid:12406167
|
Yang J et al. |
Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. |
2012 |
World J. Gastroenterol. |
pmid:22826618
|
Chen ZS et al. |
Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. |
2007 |
World J. Gastroenterol. |
pmid:17876900
|
Zhou J et al. |
Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. |
2006 |
World J. Gastroenterol. |
pmid:16718799
|
Song JL et al. |
Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. |
2016 |
World J. Gastroenterol. |
pmid:26877618
|
Li DW et al. |
Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. |
2015 |
World J. Gastroenterol. |
pmid:26034369
|
Filipec Kanizaj T and Mijic M |
Inflammatory bowel disease in liver transplanted patients. |
2017 |
World J. Gastroenterol. |
pmid:28566881
|
Provenzani A et al. |
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients. |
2013 |
World J. Gastroenterol. |
pmid:24409044
|
Guo YW et al. |
Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients. |
2016 |
World J. Gastroenterol. |
pmid:27350740
|
Kang YZ et al. |
Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation. |
2015 |
World J. Gastroenterol. |
pmid:25717264
|
Liu F et al. |
Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. |
2009 |
World J. Gastroenterol. |
pmid:19701975
|
Schott E et al. |
Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. |
2007 |
World J. Gastroenterol. |
pmid:17659718
|
Schumacher G et al. |
Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth. |
2005 |
World J. Gastroenterol. |
pmid:15770715
|
Jia JJ et al. |
''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. |
2014 |
World J. Gastroenterol. |
pmid:25170223
|
Hao JC et al. |
Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation. |
2014 |
World J. Gastroenterol. |
pmid:25170222
|
Takeichi T et al. |
Effect of ONO-4057 and tacrolimus on ischemia-reperfusion injury of the liver. |
2009 |
World J. Gastroenterol. |
pmid:19960569
|
Hilgard P et al. |
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis. |
2006 |
World J. Gastroenterol. |
pmid:16521181
|
Eshraghian A et al. |
Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level. |
2017 |
World J. Gastroenterol. |
pmid:28275302
|
Jiang JW et al. |
Optimal immunosuppressor induces stable gut microbiota after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:30228781
|
Wu SY et al. |
Comprehensive risk assessment for early neurologic complications after liver transplantation. |
2016 |
World J. Gastroenterol. |
pmid:27350733
|
Liu C et al. |
Cyclosporine A, FK-506, 40-0-[2-hydroxyethyl]rapamycin and mycophenolate mofetil inhibit proliferation of human intrahepatic biliary epithelial cells in vitro. |
2005 |
World J. Gastroenterol. |
pmid:16437685
|
Kawakami K et al. |
Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis. |
2015 |
World J. Gastroenterol. |
pmid:25684955
|
Lan X et al. |
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25232269
|
Del Bello A et al. |
High tacrolimus intra-patient variability is associated with graft rejection, and donor-specific antibodies occurrence after liver transplantation. |
2018 |
World J. Gastroenterol. |
pmid:29713132
|
Meier J and Sturm A |
Current treatment of ulcerative colitis. |
2011 |
World J. Gastroenterol. |
pmid:21912469
|
Okan G et al. |
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. |
2008 |
World J. Gastroenterol. |
pmid:18698687
|
Akamatsu N et al. |
Late-onset acute rejection after living donor liver transplantation. |
2006 |
World J. Gastroenterol. |
pmid:17075982
|
Larsen FS et al. |
Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. |
2007 |
World J. Gastroenterol. |
pmid:17589903
|
Wietzke-Braun P et al. |
Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis. |
2004 |
World J. Gastroenterol. |
pmid:15259068
|
Higashi H et al. |
First successful perinatal management of pregnancy after ABO-incompatible liver transplantation. |
2017 |
World J. Gastroenterol. |
pmid:28210092
|
Shao ZY et al. |
Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. |
2012 |
World J. Gastroenterol. |
pmid:22408361
|
Indriolo A and Ravelli P |
Clinical management of inflammatory bowel disease in the organ recipient. |
2014 |
World J. Gastroenterol. |
pmid:24707135
|
Buchholz BM et al. |
Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. |
2018 |
World J. Gastroenterol. |
pmid:30065563
|
Shen T et al. |
Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. |
2015 |
World J. Gastroenterol. |
pmid:26034381
|
Jordan ML et al. |
The use of tacrolimus in renal transplantation. |
1996 |
World J Urol |
pmid:8873438
|
Schlosser K et al. |
Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! |
2007 |
World J Surg |
pmid:17665243
|
Platz KP et al. |
Management of acute steroid-resistant rejection after liver transplantation. |
1996 |
World J Surg |
pmid:8798364
|
Sutherland DE et al. |
Pancreas transplantation for treatment of diabetes mellitus. |
2001 |
World J Surg |
pmid:11344403
|
Kato T et al. |
Intestinal and multivisceral transplantation. |
2002 |
World J Surg |
pmid:11865353
|
Motoyama K et al. |
Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats. |
1995 Mar-Apr |
World J Surg |
pmid:7538717
|
Ramakant P and Agarwal G |
Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters: surgical management of tertiary hyperparathyroidism: an enigma. |
2008 |
World J Surg |
pmid:18404286
|
Montenegro F et al. |
Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! |
2008 |
World J Surg |
pmid:18204944
|
Zong YP et al. |
Effects of CYP3A5 polymorphisms on tacrolimus pharmacokinetics in pediatric kidney transplantation: a systematic review and meta-analysis of observational studies. |
2017 |
World J Pediatr |
pmid:28540692
|
Yang EM et al. |
Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula. |
2016 |
World J Pediatr |
pmid:26684309
|
Kallash M and Aviles D |
Efficacy of tacrolimus in the treatment of children with focal segmental glomerulosclerosis. |
2014 |
World J Pediatr |
pmid:24801235
|
Schwarz C et al. |
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. |
2006 |
Wien. Klin. Wochenschr. |
pmid:16865644
|
Sperr WR et al. |
[Effector cells in allergy: biological principles and new pharmacologic concepts]. |
1993 |
Wien. Klin. Wochenschr. |
pmid:7508662
|
Haas M et al. |
Hypothyroidism as a cause of tacrolimus intoxication and acute renal failure: a case report. |
2000 |
Wien. Klin. Wochenschr. |
pmid:11144010
|
Bakardzhiev I et al. |
Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem. |
2016 |
Wien Med Wochenschr |
pmid:26762262
|
Durrant-Finn U et al. |
[Pruritus and dryness of the skin in chronic kidney insufficiency and dialysis patients - a review]. |
2009 |
Wien Med Wochenschr |
pmid:19652938
|
TruneÄka P |
[Immunosuppression after liver transplant, now and in future]. |
2013 |
Vnitr Lek |
pmid:24007221
|
Kass L et al. |
Inhibition of the calcineurin-like protein phosphatase activity in Limulus ventral eye photoreceptor cells alters the characteristics of the spontaneous quantal bumps and the light-mediated inward currents, and enhances arrestin phosphorylation. |
1998 Nov-Dec |
Vis. Neurosci. |
pmid:9839968
|
Carbajo-Lozoya J et al. |
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. |
2014 |
Virus Res. |
pmid:24566223
|
Carbajo-Lozoya J et al. |
Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. |
2012 |
Virus Res. |
pmid:22349148
|
Juvvadi PR et al. |
Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach. |
2017 |
Virulence |
pmid:27325145
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
Zhao W et al. |
Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. |
2006 |
Virology |
pmid:16828834
|